BHB
VBIV

Bank Hapoalim BM’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bank Hapoalim BM’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,333
Closed -$357K – 203
2018
Q2 		$357K Buy
4,333
+604
+16% +$58.3K 0.1% 140
2018
Q1 		$392K Buy
+3,729
New +$445K 0.1% 134

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Bank Hapoalim BM's VBIV Position: Q3 2018 in Review

Bank Hapoalim BM sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2018, closing a stake of 4,333 shares — an estimated $357K sold.

Bank Hapoalim BM first reported a position in VBIV in Q1 2018 and held it in 2 quarters. The position peaked at $392K in Q1 2018. 40 funds tracked by Wall St. Rank hold VBIV as of Q3 2018.

  • Bank Hapoalim BM reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2018 after selling out during the quarter.
  • Bank Hapoalim BM sold 4,333 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2018, an estimated $357K.
  • Bank Hapoalim BM first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2018 and held it in 2 quarters.
  • Bank Hapoalim BM's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $392K in Q1 2018.
  • 40 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2018.

Based on Bank Hapoalim BM's 13F filing for Q3 2018, filed 8 Nov 2018.